Newington, CT, United States of America

Andrew Dennis Wagner

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Laboratory Corporation of America Holdings. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Dennis Wagner. Retrieved from https://idiyas.com/inventor/andrew-dennis-wagner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • New Haven, CT (US) (2011)
  • Newington, CT (US) (2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Dennis Wagner

Introduction

Andrew Dennis Wagner is a notable inventor based in Newington, CT (US). He has made significant contributions to the field of analytical chemistry, particularly in the quantification of biological analytes. With a total of two patents to his name, Wagner's work has implications across various industries that utilize advanced analytical techniques.

Latest Patents

Wagner's latest patents include "Methods and systems for quantification of peptides and other analytes." This invention discloses LC-LC-MS/MS techniques for analyzing endogenous peptides and other highly polar small molecules. The methods and systems presented can be applied in all industries that utilize LC-MS/MS for evaluating and quantifying biological analytes in complex matrixes. Another significant patent is "Methods and systems for the quantitative analysis of biomarkers." This invention outlines methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for analyzing endogenous biomarkers, including steroid hormones like estrone and estradiol, thyroid hormones such as free thyroxine, and metabolites like 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in biological samples.

Career Highlights

Wagner is currently associated with Laboratory Corporation of America Holdings, where he applies his expertise in analytical methods. His work has been instrumental in advancing the capabilities of laboratories in the analysis of complex biological samples.

Collaborations

Wagner has collaborated with notable colleagues, including Russell Philip Grant and Mary Katherine Morr. These collaborations have likely contributed to the innovative approaches he has developed in his patents.

Conclusion

Andrew Dennis Wagner's contributions to the field of analytical chemistry through his patents demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to influence various industries that rely on precise analytical techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…